共 30 条
- [21] DISEASE-ASSOCIATED LOSS OF ERYTHROCYTE COMPLEMENT RECEPTORS (CR-1, C3B RECEPTORS) IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND OTHER DISEASES INVOLVING AUTOANTIBODIES AND OR COMPLEMENT ACTIVATIONJOURNAL OF IMMUNOLOGY, 1985, 135 (03) : 2005 - 2015ROSS, GDYOUNT, WJWALPORT, MJWINFIELD, JBPARKER, CJFULLER, CRTAYLOR, RPMYONES, BLLACHMANN, PJ
- [22] Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagenARCHIVES OF DERMATOLOGY, 1999, 135 (05) : 569 - 573Chan, LSLapiere, JCChen, MTraczyk, TMancini, AJPaller, ASWoodley, DTMarinkovich, MP
- [23] A FACTOR ACTIVATING COMPLEMENT VIA THE ALTERNATIVE PATHWAY IN THE SUPERNATANTS OF B-CELL LINES TRANSFORMED BY EPSTEIN-BARR VIRUS AND IN SERA OBTAINED FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUSINTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1988, 86 (02): : 209 - 214HIRAMATSU, MTSOKOS, GC
- [24] INCREASED AMOUNTS OF C4-CONTAINING IMMUNE-COMPLEXES AND INEFFICIENT ACTIVATION OF C3 AND THE TERMINAL COMPLEMENT PATHWAY IN A PATIENT WITH HOMOZYGOUS C2 DEFICIENCY AND SYSTEMIC LUPUS-ERYTHEMATOSUSSCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 31 (01) : 59 - 64GARRED, PMOLLNES, TETHORSTEINSSON, LERLENDSSON, KSTEINSSON, K
- [25] RELEASE OF PLATELET-ACTIVATING FACTOR IN HUMAN PATHOLOGY .1. EVIDENCE FOR THE OCCURRENCE OF BASOPHIL DE-GRANULATION AND RELEASE OF PLATELET-ACTIVATING FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUSLABORATORY INVESTIGATION, 1981, 44 (03) : 241 - 251CAMUSSI, GTETTA, CCODA, RBENVENISTE, J
- [26] STUDIES ON HUMAN-BLOOD LYMPHOCYTES WITH IC3B (TYPE-3) COMPLEMENT RECEPTORS .1. ANTIGRANULOCYTES, FC-IGG RECEPTOR POSITIVE AND NEGATIVE SUBSETS IN HEALTHY-SUBJECTS AND PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUSJOURNAL OF IMMUNOLOGY, 1986, 136 (04) : 1253 - 1259BAKKE, ACGRAY, JDABO, WQUISMORIO, FPLASH, ACOOPER, SMHORWITZ, DA
- [27] LOW NUMBER OF COMPLEMENT C3B/C4B RECEPTORS (CR-1) ON ERYTHROCYTES FROM PATIENTS WITH ESSENTIAL MIXED CRYOGLOBULINEMIA, SYSTEMIC LUPUS-ERYTHEMATOSUS AND RHEUMATOID-ARTHRITIS - RELATIONSHIP WITH DISEASE-ACTIVITY, ANTICARDIOLIPIN ANTIBODIES, COMPLEMENT ACTIVATION AND THERAPYJOURNAL OF RHEUMATOLOGY, 1991, 18 (07) : 1021 - 1025CORVETTA, APOMPONIO, GBENCIVENGA, RLUCHETTI, MMSPYCHER, MSPAETH, PJDANIELI, G
- [28] STAT1 Activation Promotes TLR8 Overexpression and Facilitates Mirokine Signaling Via Exosomes Containing a Mir-21 Endogenous Ligand: A Novel Innate Inflammatory Pathway in Systemic Lupus ErythematosusARTHRITIS & RHEUMATOLOGY, 2015, 67Valiente, Giancarlo R.Young, Nicholas A.Wu, Lai-ChuHampton, JeffreySeverin, MaryLovett-Racke, AmyJarjour, Wael N.
- [29] Estrogen-mediated TLR8 expression via STAT1 facilitates endogenous miRokine ligand activation through miR-21-containing exosomes: a novel innate inflammatory pathway in systemic lupus erythematosusCLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S18 - S18Young, N. A.Wu, L.Amici, S.Guerau, M.Severin, M.Lovett-Racke, A.Valiente, G.Burd, C.Hampton, J.Jarjour, W. N.
- [30] ESTROGEN-REGULATED STAT1 ACTIVATION PROMOTES TLR8 OVEREXPRESSION AND FACILITATES MIROKINE SIGNALING VIA EXOSOMES CONTAINING MIR-21 ENDOGENOUS LIGAND: A NOVEL INNATE INFLAMMATORY PATHWAY IN SYSTEMIC LUPUS ERYTHEMATOSUSANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 906 - 907Young, N. A.Wu, L. -C.Amici, S.Guerau, M.Severin, M.Lovett-Racke, A.Valiente, G.Burd, C.Hampton, J.Jarjour, W.